Rommen Mueller Sybert Syndrome Overview

Save information for later
Sign Up

Learn About Rommen Mueller Sybert Syndrome

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Rommen Mueller Sybert Syndrome Local Doctors?
Elite in Rommen Mueller Sybert Syndrome
Elite in Rommen Mueller Sybert Syndrome
Tokyo, JP 

Reiko Horikawa practices in Tokyo, Japan. Ms. Horikawa is rated as an Elite expert by MediFind in the treatment of Rommen Mueller Sybert Syndrome. Her top areas of expertise are Pediatric Growth Hormone Deficiency, Small for Gestational Age, Rommen Mueller Sybert Syndrome, Liver Transplant, and Hormone Replacement Therapy (HRT).

Distinguished in Rommen Mueller Sybert Syndrome
Pediatric Cardiology
Distinguished in Rommen Mueller Sybert Syndrome
Pediatric Cardiology

Children's National Hospital

111 Michigan Ave NW, 
Washington, DC 
Languages Spoken:
English

Niti Dham is a Pediatric Cardiologist in Washington, Washington, D.c.. Dr. Dham is rated as a Distinguished provider by MediFind in the treatment of Rommen Mueller Sybert Syndrome. Her top areas of expertise are Hypochondroplasia, Rommen Mueller Sybert Syndrome, Multisystem Inflammatory Syndrome in Children (MIS-C), and Pediatric Myocarditis.

 
 
 
 
Learn about our expert tiers
Learn More
Stacy Fisher
Advanced in Rommen Mueller Sybert Syndrome
Cardiology
Advanced in Rommen Mueller Sybert Syndrome
Cardiology

Greater Baltimore Medical Center

6569 North Charles Street, Pavilion West STE 600, Pavilion West STE 600, 
Baltimore, MD 
Languages Spoken:
English
Offers Telehealth

Dr. Stacy Fisher is a cardiologist in Baltimore, Maryland specializing in the care of adult congenital heart disease, pregnancy-related heart disease and congenital heart pulmonary hypertension. She is Associate Director of the Adult Congenital Heart Disease (ACHD) Center at the Johns Hopkins Heart and Vascular Institute and Director of the ACHD Training Program. She is also an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. Her research focus is congenital heart disease in adults including pulmonary hypertension, inherited heart disease and 3D printing translational medicine. She is interested in imaging and using 3D modeling to advance cardiac care and education. Her education includes a Bachelor of Science degree in Microbiology from Miami University in Oxford, Ohio, and a Doctor of Medicine Degree from the University of Maryland School of Medicine in Baltimore, Maryland. She completed an internship and residency in Internal Medicine at Duke University in Durham, North Carolina. Her fellowship in cardiology was at the University of Rochester, Strong Memorial Hospital in Rochester, New York, including serving as the Chief Cardiology Fellow. She was then an Adult Congenital Heart Fellow at the University of Rochester, Strong Memorial Hospital. After completing her fellowship in 2001, she joined a Baltimore cardiology practice and was named Director of Women’s Cardiovascular Services and the Co-Director of the Cardiac Critical Care Unit at Sinai Hospital in Baltimore, positions which she held until 2011. She then joined University of Maryland School of Medicine as Director of Women’s and Complex Heart diseases where she started and directed the Adult Congenital Heart Program and practiced through 2022 when she joined Johns Hopkins. She was recently the President of the American Heart Association’s Greater Maryland Region. Videos Dr. Stacy Fisher. Dr. Fisher is rated as an Advanced provider by MediFind in the treatment of Rommen Mueller Sybert Syndrome. Her top areas of expertise are Familial Ventricular Tachycardia, Arrhythmias, Ventricular Tachycardia, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

What are the latest Rommen Mueller Sybert Syndrome Clinical Trials?
A Phase 2, Randomized, Human Growth Hormone-Controlled, Multicenter, Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome With an Inadequate Response to Human Growth Hormone. (CANOPY NS, TS, SHOX-D-2)

Summary: The purpose of this basket study in children with Turner syndrome, SHOX deficiency, and Noonan syndrome is to evaluate the effect of 3 doses of vosoritide versus hGH on growth as measured by AGV after 6 months of treatment. The long-term efficacy and safety of vosoritide at the therapeutic dose will be evaluated up to FAH.

Match to trials
Find the right clinical trials for you in under a minute
Get started